본문 바로가기
Ildong Holdings
Ildong Pharmaceutical
Ildong Bioscience
Group Site
Yunovia
iLeadBMS
Idience
Aimsbioscience
Ethical Management
ENG
KOR
Company
Company
Company continuing to grow through positive changes and innovations
Greeting
About Us
Introduction
Philosophy/Vision
CI
History
Group Affiliates
Healthcare
Investing
Advertising
IT
Foundation
Compliance Program
Ethical Management
Introduction
Compliance Organization
Manufacturing Facilities
Introduction
Anseong Plant
Cheongju Plant
Consignment
NEWS
Location
Product
Product
Explore Ildong Pharmaceutical’s wide range of products.
Product Search
Finished Drugs(ETC)
Finished Drugs(OTC)
Raw Material Drugs
Health Supplements & Foods
Cosmetics
Medical Device
Others
Brand Stories
Aronamin
Biovita
Investor Information
Investor Information
Creating sustainable growth through transparent management
Share Information
Financial Information
Financial Status
IR
Disclosure Information
Notice
Financial Results
R&D
R&D
A vision-driven and value-generating global healthcare group
Strategy
Mission & Vision
R&D Strategy
Core Capabilities
Internal Organization
Ecosystem
Ildong Pharmaceutical
AIMS BioScience
Idience
iLEAD BMS
External Network
Pipeline
Global Business
Global Business
Welcomes all inquiries.
Status of Overseas Expansion
Business Model
UN SDGBI
Contact us
NEWS
Ildong Pharmaceutical’s latest developments and activities
Home
Company
NEWS
NEWS
Total Posts
45
All
Title
Contents
Search
Title, Registered On, Views table
NO
Title
Registered On
Views
45
Ildong Pharmaceutical Expands 'Droptop' Hyperlipidemia Treatment into 3 Additional ASEAN Countries
2026.06.02
38
44
Ildong Pharmaceutical Signs Exclusive Distribution and Promotion Agreement with Viatris Korea in Urology Segment
2026.06.02
38
43
Idience's Targeted Anticancer Drug Venadaparib Receives FDA 'Fast Track' Designation
2026.06.02
38
42
Ildong Group Explores Business Opportunities at 'EAST-WEST Biopharma Summit' Seoul Event
2026.06.02
37
41
Ildong Pharmaceutical Group Chairman Won-young Yun Receives 'Korea Pharmaceutical Industry Award'
2026.06.02
37
40
Ildong Pharmaceutical Renews 'ISO 27001' and 'ISO 27701' International Standards Certifications for Information Protection and Management
2026.06.02
2
39
Ildong Pharmaceutical Launches PDRN-Containing Functional Cosmetic 'Rejuniq Cream' in Pharmacies
2026.06.02
2
38
Ildong Pharmaceutical Group Pursues Partnering Activities Including 'GLP-1RA Obesity Drug' at 'BIO-Europe'
2026.06.02
2
37
Ildong Pharmaceutical Group to Pursue Global Commercialization of 'P-CAB Novel Drug' at 'CPHI' and 'BIO-Europe'
2026.06.02
2
36
Ildong Pharmaceutical Group Opens 'Dongnyeokgwan', a Corporate History Exhibition Hall
2026.06.02
5
처음페이지
이전페이지
1
2
3
4
5
다음
마지막페이지